Liu Qiquan

Hebei Liu Qiquan Pharmaceutical Technology is a Chinese biotechnology and pharmaceutical company focused on the research, development, and clinical application of Traditional Chinese Medicine (TCM) for gastrointestinal disorders. Founded by the National Famous TCM Doctor Professor Liu Qiquan, the company commercializes proprietary herbal formulas and therapeutic protocols developed through decades of clinical practice at the Hebei Provincial Hospital of Traditional Chinese Medicine. Its core expertise lies in the "One Descent, Two Regulations, Three Combinations" (一降、二调、三结合) therapeutic framework, which aims to reverse gastric mucosal atrophy and intestinal metaplasia. The company's product portfolio includes specialized TCM series such as Wei An and Chang Ning, targeting chronic atrophic gastritis and ulcerative colitis, respectively. The entity operates as a bridge between academic research at Hebei University of Chinese Medicine and commercial pharmaceutical production.